Intensive BP target reduces LVH rates, increases LVH regression

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway 

  • Targeting a systolic BP (SBP) of <120 mmHg among patients with hypertension without diabetes is associated with reduced rates of left ventricular hypertrophy (LVH) and increased rates of LVH regression. 

Why this matters  

  • This analysis from the SPRINT trial focuses on LVH, an important marker of end-organ damage and common in hypertension.
  • A previous analysis of data from the ACCORD trial showed benefits of <120 mmHg targets for patients with diabetes and hypertension, they had a reduced risk for LVH as well...